PTEN and hepatocellular carcinoma: Further studies on the mechanism showed that miR-23a-3p delivered to TAMs by HCC cells activated the PI3K-AKT pathway by inhibiting PTEN expression, thereby upregulating PD-L1 expression in TAMs and suppressing T-cell function.